Howard Shelanski
Lawyers
Filters
Davis Polk Advises Aetna on the U.S. Department of Justice Approval of Its Acquisition by CVS Health
Davis Polk is advising Aetna in connection with an agreement with the U.S. Department of Justice that allows it to proceed with its proposed $77 billion acquisition by CVS Health and its…
Davis Polk Advises Heineken on its Non-Binding Agreements with China Resources to Join Forces in China
Davis Polk is advising Heineken N.V. in connection with its non-binding agreements with China Resources Enterprise (“CRE”) and China Resources Beer (Holdings) Co. Ltd. (“CR Beer”) to create…
Davis Polk Advises Services Group of America on the Sale of Its Food Group of Companies to US Foods
Davis Polk is advising Services Group of America on the $1.8 billion sale of its five operating companies collectively known as SGA’s Food Group of Companies to US Foods Holding Corp. The…
Davis Polk Advises Williams on the Sale of Williams Partners’ Four Corners Area Business to Harvest Midstream
Davis Polk is advising Williams on its $1.125 billion combined sale of assets and equity comprising Williams Partners L.P.’s Four Corners Area business in New Mexico and Colorado to Harvest…
Davis Polk Advises Aptiv on Its Acquisition of Winchester Interconnect
Davis Polk is advising Aptiv PLC on its acquisition of Winchester Interconnect from an affiliate of Snow Phipps Group for $650 million. The transaction is subject to regulatory approval and…
Davis Polk Advises IHS Markit on Its Acquisition of Ipreo
Davis Polk is advising IHS Markit on its $1.855 billion acquisition of Ipreo from private equity funds managed by Blackstone and the Goldman Sachs Merchant Banking Division. The acquisition…
Davis Polk Advises Stewart on Its Acquisition by Fidelity National Financial
Davis Polk is advising Stewart Information Services Corporation on its approximately $1.2 billion acquisition by Fidelity National Financial, Inc. The transaction, which is expected to…
Aetna $77 billion acquisition by CVS Health
Davis Polk is advising Aetna on its approximately $77 billion acquisition by CVS Health. The transaction, which is expected to close in the second half of 2018, is subject to approval by…
Advanced Accelerator Applications $3.9 billion acquisition by Novartis
Davis Polk is advising Advanced Accelerator Applications S.A. on its $3.9 billion acquisition by Novartis. Entry into the definitive agreement has been approved by the board of…
Davis Polk Advises Tyson Foods on Its Acquisition of AdvancePierre Foods
Davis Polk is advising Tyson Foods, Inc. on its approximately $4.2 billion acquisition of AdvancePierre Foods Holdings, Inc. The transaction, which is expected to close in the third quarter…